Medium | Q01279 | Epidermal growth factor receptor OS=Mus musculus OX=10090 GN=Egfr PE=1 SV=1 | 0.021 | 2.162 | 1 | 1 | 1 | 1 | 1210 | 134.8 | 6.86 | | 1 | | | 1 | | 1221633.625 | 2770787.5 | 3689878.25 | 1 | 1 | 1 | | cell organization and biogenesis;cell proliferation;cellular component movement;development;metabolic process;regulation of biological process;response to stimulus;transport | cell surface;cytoplasm;endoplasmic reticulum;endosome;Golgi;membrane;nucleus;organelle lumen | catalytic activity;enzyme regulator activity;nucleotide binding;protein binding;receptor activity;signal transducer activity | "Pf00069, Pf00757, Pf01030, Pf07714, Pf14843" | 13649 | ENSMUSG00000020122.16 | Egfr | 11 | "EGFR interacts with phospholipase C-gamma; Downregulation of ERBB2 signaling; GAB1 signalosome; Signaling by GPCR; EGFR downregulation; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; ERBB2 Regulates Cell Motility; SHC1 events in EGFR signaling; Interleukin-20 family signaling; Signaling by ERBB4; EGFR Transactivation by Gastrin; PI3K events in ERBB2 signaling; RAF/MAP kinase cascade; PTK6 promotes HIF1A stabilization; GRB2 events in EGFR signaling; ERBB2 Activates PTK6 Signaling; Signal transduction by L1; Cargo recognition for clathrin-mediated endocytosis; SHC1 events in ERBB2 signaling" | Oxytocin signaling pathway; ErbB signaling pathway; FoxO signaling pathway; Endocytosis; Phospholipase D signaling pathway; Regulation of actin cytoskeleton; MAPK signaling pathway; MicroRNAs in cancer; Ras signaling pathway; Focal adhesion; Endometrial cancer; Breast cancer; Melanoma; Non-small cell lung cancer; Adherens junction; Dorso-ventral axis formation; Proteoglycans in cancer; Rap1 signaling pathway; HIF-1 signaling pathway; Pathways in cancer; Calcium signaling pathway; Hepatitis C; Pancreatic cancer; PI3K-Akt signaling pathway; GnRH signaling pathway; Gap junction; Glioma; EGFR tyrosine kinase inhibitor resistance; Central carbon metabolism in cancer; Choline metabolism in cancer; Estrogen signaling pathway; Cytokine-cytokine receptor interaction; Prostate cancer; Endocrine resistance; Bladder cancer | 0 |